{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:19:03Z","timestamp":1761293943686,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.anl.2018.12.013","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T08:15:09Z","timestamp":1559722509000},"page":"882-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"46","author":[{"given":"Hiroshi","family":"Okuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2018.12.013_bib0005","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2018.12.013_bib0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2018.12.013_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CMAR.S35785","article-title":"Nedaplatin: a cisplatin derivative in cancer chemotherapy","volume":"8","author":"Shimada","year":"2013","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.anl.2018.12.013_bib0020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1248\/bpb.28.1385","article-title":"Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation","volume":"28","author":"Kawai","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.anl.2018.12.013_bib0025","first-page":"951","article-title":"Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas","volume":"30","author":"Yamaoka","year":"2003","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0030","first-page":"3493","article-title":"Ef\ufb01cacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas","volume":"23","author":"Kato","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anl.2018.12.013_bib0035","first-page":"323","article-title":"Antitumor activity of a new platinum compound (glycolate-o,o\u2019) diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system","volume":"8","author":"Kanzawa","year":"1988","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anl.2018.12.013_bib0040","first-page":"201","article-title":"Pilot study of concomitant TS-1\/CDGP radiotherapy for esophageal cancer","volume":"32","author":"Inaba","year":"2005","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10388-011-0261-0","article-title":"Prospective study of definitive chemoradiotherapy with S-1 and nedaplatin in patients with stage II\/III (non-T4) esophageal cancer","volume":"8","author":"Tsuda","year":"2011","journal-title":"Esophagus"},{"key":"10.1016\/j.anl.2018.12.013_bib0050","first-page":"863","article-title":"An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers","volume":"19","author":"Inuyama","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0055","first-page":"871","article-title":"A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers","volume":"19","author":"Inuyama","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jjco\/hyl138","article-title":"Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer","volume":"37","author":"Fuwa","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0065","first-page":"53","article-title":"Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer","volume":"25","author":"Fujii","year":"1998","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0070","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(98)00194-4","article-title":"Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model","volume":"34","author":"Uchida","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anl.2018.12.013_bib0075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00001813-199810000-00012","article-title":"Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-\ufb02uorouracil","volume":"9","author":"Fukushima","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.anl.2018.12.013_bib0080","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.ejca.2013.07.003","article-title":"Combination of cisplatin\/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: results of noninferiority and safety analyses compared with cisplatin\/5-fluorouracil in the first-line advanced gastric cancer study","volume":"49","author":"Ajani","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anl.2018.12.013_bib0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10120-015-0587-8","article-title":"The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis","volume":"19","author":"Ter Veer","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.anl.2018.12.013_bib0090","first-page":"1381","article-title":"Late phase II study of S-1 in patients with advanced head and neck cancer","volume":"28","author":"Inuyama","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.anl.2018.12.013_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198391","article-title":"Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: reanalysis of the ACTS-HNC study","volume":"13","author":"Kubota","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.anl.2018.12.013_bib0100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3109\/00016489.2011.590153","article-title":"Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer","volume":"131","author":"Furusaka","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2018.12.013_bib0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/jjco\/hyq196","article-title":"Ef\ufb01cacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer","volume":"41","author":"Ohashi","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0110","first-page":"2065","article-title":"Phase I trial concurrent combined TS-1 and nedaplatin","volume":"32","author":"Takemura","year":"2005","journal-title":"Jpn J Cancer Chemother"},{"key":"10.1016\/j.anl.2018.12.013_bib0115","first-page":"63","article-title":"Change of chemotherapy to stage III and IV laryngeal cancer and the therapeutic effect","volume":"31","author":"Takemura","year":"2005","journal-title":"Nippon Toukeibugan Gakkai Zasshi"},{"key":"10.1016\/j.anl.2018.12.013_bib0120","series-title":"The handbook of cancer chemotherapy","first-page":"40","article-title":"CDGP\u2009+\u2009S-1 therapy","author":"Iida","year":"2004"},{"key":"10.1016\/j.anl.2018.12.013_bib0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anl.2018.12.013_bib0130","unstructured":"National Cancer Institute Cancer Therapy Evaluation Program [Internet]. U.S.: Department of National Institutes of Health; c2009. Available from: https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html. [Cited 1 April 2018]."},{"key":"10.1016\/j.anl.2018.12.013_bib0135","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2004.12.012","article-title":"Preliminary results of radiation therapy oncology group 97\u201303: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck","volume":"22","author":"Garden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0140","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck Cancer: an RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2017.07.003","article-title":"Treatment of late sequelae after radiotherapy for head and neck cancer","volume":"59","author":"Strojan","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.anl.2018.12.013_bib0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hed.23265","article-title":"Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional study","volume":"36","author":"van den Berg","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2018.12.013_bib0155","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/annonc\/mdp573","article-title":"Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study","volume":"21","author":"Paccagnella","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00066-013-0509-9","article-title":"Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck","volume":"190","author":"Balermpas","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.anl.2018.12.013_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00016489.2014.952046","article-title":"Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer","volume":"135","author":"Hoshikawa","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2018.12.013_bib0170","doi-asserted-by":"crossref","first-page":"754191","DOI":"10.1155\/2012\/754191","article-title":"Hyperfractionated radiotherapy with concurrent cisplatin\/5-fluorouracil for locoregional advanced head and neck cancer: analysis of 105 consecutive patients","volume":"2012","author":"Zaboli","year":"2012","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.anl.2018.12.013_bib0175","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.2005.01.5867","article-title":"Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution","volume":"24","author":"Adelstein","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0180","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2018.12.013_bib0185","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3109\/00016489.2011.616226","article-title":"Comparison of the efficacy and toxicity of two dose levels of cisplatin\/5-fluorouracil as the chemoradiotherapy regimen for the treatment of locally advanced squamous cell carcinoma of the head and neck","volume":"131","author":"Su","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2018.12.013_bib0190","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/cas.12657","article-title":"Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)","volume":"106","author":"Tahara","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2018.12.013_bib0195","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2014.12.032","article-title":"Phase 2 Study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck","volume":"91","author":"Inohara","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anl.2018.12.013_bib0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN guidelines insights: head and neck cancers, version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J Natl Compr Cancer Network"},{"key":"10.1016\/j.anl.2018.12.013_bib0205","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jrr\/rrv038","article-title":"Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients","volume":"56","author":"Kurokawa","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.anl.2018.12.013_bib0210","doi-asserted-by":"crossref","first-page":"904341","DOI":"10.1155\/2014\/904341","article-title":"Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment","volume":"2014","author":"Hu","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.anl.2018.12.013_bib0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2010.11.009","article-title":"Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in local advanced head and neck squamous cell cancer (LAHNSCC)","volume":"98","author":"Walsh","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx Cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 french head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2018.12.013_bib0230","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/hed.20379","article-title":"Phase I\/II study of S-1 combined with carboplatin in recurrent and\/or metastatic head and neck cancer as outpatient chemotherapy","volume":"28","author":"Watanabe","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2018.12.013_bib0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.critrevonc.2016.04.004","article-title":"Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model","volume":"102","author":"Strigari","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.anl.2018.12.013_bib0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.oraloncology.2015.05.003","article-title":"Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer","volume":"51","author":"Kraaijenga","year":"2015","journal-title":"Oral Ocol"},{"key":"10.1016\/j.anl.2018.12.013_bib0245","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2013.03.005","article-title":"Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures","volume":"106","author":"van der Molen","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814618305807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814618305807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:35:55Z","timestamp":1759952155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814618305807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0385814618305807"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2018.12.013","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2018.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}